PAEP and ovarian cancer: The glycodelin protein purified from the malignant ascites of ovarian cancer patients, also hinders the maturation of DCs with the tolerogenic phenotype and functionality (80), which suggests glycodelin can form an immunosuppressive microenvironment in cancer progression (Figure 1).